These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

167 related items for PubMed ID: 9015034

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Management of pregnancies complicated by anti-E alloimmunization.
    Joy SD, Rossi KQ, Krugh D, O'Shaughnessy RW.
    Obstet Gynecol; 2005 Jan; 105(1):24-8. PubMed ID: 15625137
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities.
    Nordvall M, Dziegiel M, Hegaard HK, Bidstrup M, Jonsbo F, Christensen B, Hedegaard M.
    Transfusion; 2009 Oct; 49(10):2070-5. PubMed ID: 19497053
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effect of screening for red cell antibodies, other than anti-D, to detect hemolytic disease of the fetus and newborn: a population study in the Netherlands.
    Koelewijn JM, Vrijkotte TG, van der Schoot CE, Bonsel GJ, de Haas M.
    Transfusion; 2008 May; 48(5):941-52. PubMed ID: 18248570
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The risk assessment study for hemolytic disease of the fetus and newborn in a University Hospital in Turkey.
    Altuntas N, Yenicesu I, Himmetoglu O, Kulali F, Kazanci E, Unal S, Aktas S, Hirfanoglu I, Onal E, Turkyilmaz C, Ergenekon E, Koc E, Atalay Y.
    Transfus Apher Sci; 2013 Jun; 48(3):377-80. PubMed ID: 23619329
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of maternal red cell alloimmunisation: a population study from Queensland, Australia.
    Pal M, Williams B.
    Pathology; 2015 Feb; 47(2):151-5. PubMed ID: 25551305
    [Abstract] [Full Text] [Related]

  • 12. Prognostic factors and management in pregnancies complicated with severe kell alloimmunization: experiences of the last 13 years.
    Babinszki A, Lapinski RH, Berkowitz RL.
    Am J Perinatol; 1998 Feb; 15(12):695-701. PubMed ID: 10333397
    [Abstract] [Full Text] [Related]

  • 13. Current clinical management of anti-Kell alloimmunization in pregnancy.
    Santiago JC, Ramos-Corpas D, Oyonarte S, Montoya F.
    Eur J Obstet Gynecol Reprod Biol; 2008 Feb; 136(2):151-4. PubMed ID: 17481801
    [Abstract] [Full Text] [Related]

  • 14. Management of anti-Jka alloimmunization.
    Franco A, Rossi K, Krugh D, O'Shaughnessy R.
    J Reprod Med; 2009 Mar; 54(3):121-5. PubMed ID: 19370894
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Haemolytic disease of the newborn--from a mother with anti-Kell, anti-E and anti-Vel anti-erythrocyte alloantibodies].
    Vućinović M, Jadrić H, Karelović D, Roje D, Haspl-Hundrić Z, Hrgović Z, Vućinović Z.
    Z Geburtshilfe Neonatol; 2004 Oct; 208(5):197-202. PubMed ID: 15508054
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Alloimmunization to red cells in thalassemics: emerging problem and future strategies.
    Gupta R, Singh DK, Singh B, Rusia U.
    Transfus Apher Sci; 2011 Oct; 45(2):167-70. PubMed ID: 21856231
    [Abstract] [Full Text] [Related]

  • 20. Risk of maternal alloimmunization in Southern Pakistan - a study in a cohort of 1000 pregnant women.
    Karim F, Moiz B, Kamran N.
    Transfus Apher Sci; 2015 Feb; 52(1):99-102. PubMed ID: 25532481
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.